Treatment and prevention options for respiratory syncytial virus infections
- 1 May 1994
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 124 (5), S22-S27
- https://doi.org/10.1016/s0022-3476(94)70187-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia—RSV recombinants or RSVVaccine, 1992
- Early ribavirin treatment of respiratory syncytial viral infection in high-risk childrenThe Journal of Pediatrics, 1990
- Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6 months after immunizationVaccine, 1990
- In re ribavirin: A case of premature adjudication?The Journal of Pediatrics, 1988
- Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton ratVirus Research, 1985
- MONOCLONAL ANTIBODIES PROTECT AGAINST RESPIRATORY SYNCYTIAL VIRUSThe Lancet, 1983
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionNew England Journal of Medicine, 1983
- Parenteral Administration of Live Respiratory Syncytial Virus Vaccine: Results of a Field TrialThe Journal of Infectious Diseases, 1982
- Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody levelThe Journal of Pediatrics, 1981
- Pathological changes in virus infections of the lower respiratory tract in childrenJournal of Clinical Pathology, 1970